09Sep
09Sep
Local Biotech Firm Develops Drug For Respiratory Distress In COVID-19 Patients
Pittsburgh-based biotech company CytoAgents is launching into phase one of clinical trials this month on a drug designed to treat people with COVID-19 who develop serious respiratory distress when their immune system overreacts to the virus. Read more >>
05Sep
VC funding update: Boston startups and tech firms raised $1.3B in August
The VC summer slowdown may be real after all. Last month, Boston-area startups and tech firms raised a collective $1.3B—a formidable number, but nothing approximating July’s $6.9B. Waltham-based Pyramid Biosciences raised $8.8M in equity in an $18M funding round, according to an SEC filing. Read more >>
04Sep
Board adds $1M to help get more Utah students connected to internet
The board also approved setting aside $452,000 from the Utah K-12 CARES set aside funds to obtain a K-12 license for Scrible. Scrible is a tech-based writing, research, annotation and collaboration platform to support digital learning and teaching. Read more >>
04Sep
Managing Your Student Loan Payments During COVID-19
The COVID-19 pandemic has affected nearly every aspect of life on a global scale. As we are forced to observe varying degrees of shelter-in-place and phased reopenings, millions of Americans are out of work and searching for their next paycheck. If you find yourself in this situation and you have student loan debt, you might be worried about making payments. On the other hand, you may be fortunate enough to make your payments but aren’t sure where to start.
03Sep
Myomo® Receives First Australian Insurance Authorization for MyoPro™
Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that a Myomotrained Orthotic & Prosthetic (“O&P”) practice in Australia has received its first insurance authorization to fit a patient with a custom MyoPro device. Read more >>
02Sep
Jay Blankenship M.D. Joins Zylö as Vice President of Business Development
Zylö Therapeutics Inc., developer of the transformational Z-pod™ topical delivery platform, announced Jay Blankenship M.D. has joined its executive team as vice president of business development. Read more >>
02Sep
TRACER to support Akston Biosciences’ Phase 1 clinical study of AKS-452, an innovative anti-COVID-19 vaccine
BEVERLY, Mass., USA & GRONINGEN, the Netherlands, Sept. 01, 2020 Today, TRACER Europe B.V., a Clinical Research Organization (CRO) specializing in fast-track solutions for testing innovative biologic medicines, announced that it will support Akston Biosciences Inc., a leader in the development of novel Fc fusion protein therapeutics, in the Phase 1 clinical testing in the Netherlands of Akston’s lead COVID-19 vaccine candidate, AKS-452. Read more >>
28Aug
KnipBio says its SCP meal has benefits for RAS production
KnipBio reports that fish fed a diet containing 5% of its KnipBio Meal (KBM) – a single cell protein - had signicantly lower levels of geosmin and methylisoborneol (MIB), the compounds responsible for creating off-flavors in RAS-raised fish. Read more >>
27Aug